Nasopharyngeal carcinoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
| Line 7: | Line 7: | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals, in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa, southern China and middle east with the incidence of 80 per 100,000 individuals.<ref name="CaponigroLongo2010">{{cite journal|last1=Caponigro|first1=Francesco|last2=Longo|first2=Francesco|last3=Ionna|first3=Franco|last4=Perri|first4=Francesco|title=Treatment approaches to nasopharyngeal carcinoma: a review|journal=Anti-Cancer Drugs|volume=21|issue=5|year=2010|pages=471–477|issn=0959-4973|doi=10.1097/CAD.0b013e328337160e}}</ref><ref name="LeeNg2012">{{cite journal|last1=Lee|first1=Anne W.M.|last2=Ng|first2=W.T.|last3=Chan|first3=Y.H.|last4=Sze|first4=Henry|last5=Chan|first5=Connie|last6=Lam|first6=T.H.|title=The battle against nasopharyngeal cancer|journal=Radiotherapy and Oncology|volume=104|issue=3|year=2012|pages=272–278|issn=01678140|doi=10.1016/j.radonc.2012.08.001}}</ref> | *The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals, in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa, southern China and middle east with the incidence of 80 per 100,000 individuals.<ref name="CaponigroLongo2010">{{cite journal|last1=Caponigro|first1=Francesco|last2=Longo|first2=Francesco|last3=Ionna|first3=Franco|last4=Perri|first4=Francesco|title=Treatment approaches to nasopharyngeal carcinoma: a review|journal=Anti-Cancer Drugs|volume=21|issue=5|year=2010|pages=471–477|issn=0959-4973|doi=10.1097/CAD.0b013e328337160e}}</ref><ref name="LeeNg2012">{{cite journal|last1=Lee|first1=Anne W.M.|last2=Ng|first2=W.T.|last3=Chan|first3=Y.H.|last4=Sze|first4=Henry|last5=Chan|first5=Connie|last6=Lam|first6=T.H.|title=The battle against nasopharyngeal cancer|journal=Radiotherapy and Oncology|volume=104|issue=3|year=2012|pages=272–278|issn=01678140|doi=10.1016/j.radonc.2012.08.001}}</ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
| Line 20: | Line 13: | ||
===Age=== | ===Age=== | ||
*The incidence of nasopharyngeal carcinoma increases with increasing age in low- risk population. However, in high risk populations, the maximum incidence is seen in indivituals around ages 50 to 59 and then the incidence decreases by increasing age . | |||
*The incidence of | |||
===Race=== | ===Race=== | ||
| Line 30: | Line 19: | ||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | *[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | ||
===Gender=== | ===Gender=== | ||
* | *Nasopharyngeal carcinoma are more commonly affected by male than female. The male to female ratio is approximately 2-3 to 1. | ||
===Region=== | ===Region=== | ||
| Line 37: | Line 25: | ||
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | *[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | ||
==Demographics== | ==Demographics== | ||
* | * | ||
*[[Nasopharyngeal carcinomas]] account for approximately 70% of all primary malignancies of the [[nasopharynx]]. | *[[Nasopharyngeal carcinomas]] account for approximately 70% of all primary malignancies of the [[nasopharynx]]. | ||
*Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China. | *Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China. | ||
==References== | ==References== | ||
Revision as of 17:42, 15 February 2019
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics |
|
FDA on Nasopharyngeal carcinoma epidemiology and demographics |
|
CDC on Nasopharyngeal carcinoma epidemiology and demographics |
|
Nasopharyngeal carcinoma epidemiology and demographics in the news |
|
Blogs on Nasopharyngeal carcinoma epidemiology and demographics |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
Epidemiology and Demographics
Incidence
- The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals, in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa, southern China and middle east with the incidence of 80 per 100,000 individuals.[1][2]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- The incidence of nasopharyngeal carcinoma increases with increasing age in low- risk population. However, in high risk populations, the maximum incidence is seen in indivituals around ages 50 to 59 and then the incidence decreases by increasing age .
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Nasopharyngeal carcinoma are more commonly affected by male than female. The male to female ratio is approximately 2-3 to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Demographics
- Nasopharyngeal carcinomas account for approximately 70% of all primary malignancies of the nasopharynx.
- Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China.
References
- ↑ Caponigro, Francesco; Longo, Francesco; Ionna, Franco; Perri, Francesco (2010). "Treatment approaches to nasopharyngeal carcinoma: a review". Anti-Cancer Drugs. 21 (5): 471–477. doi:10.1097/CAD.0b013e328337160e. ISSN 0959-4973.
- ↑ Lee, Anne W.M.; Ng, W.T.; Chan, Y.H.; Sze, Henry; Chan, Connie; Lam, T.H. (2012). "The battle against nasopharyngeal cancer". Radiotherapy and Oncology. 104 (3): 272–278. doi:10.1016/j.radonc.2012.08.001. ISSN 0167-8140.